Renal Cancer - Results from #1200

The Non-Interventional PAZOREAL Study to Assess the Effectiveness and Safety of Pazopanib in a Real-Life Setting: Reflecting a Changing mRCC Treatment Landscape. November 28, 2022

Identification of molecular subtypes based on chromatin regulator and tumor microenvironment infiltration characterization in papillary renal cell carcinoma. November 25, 2022

Preoperative neutrophil-lymphocyte ratio/platelet-lymphocyte ratio: A potential and economical marker for renal cell carcinoma. November 25, 2022

End-of-Life Care for Patients With Metastatic Renal Cell Carcinoma in the Era of Oral Anticancer Therapy. November 24, 2022

Cabozantinib Safety With Different Anticoagulants in Patients With Renal Cell Carcinoma. November 24, 2022

French AFU Cancer Committee Guidelines - Update 2022-2024: management of kidney cancer. November 23, 2022

Transcriptomic recurrence score improves recurrence prediction for surgically treated patients with intermediate-risk clear cell kidney cancer. November 23, 2022

5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney). November 22, 2022

Cancer specific mortality in patients with collecting duct vs. clear cell renal carcinoma. November 22, 2022

Quality-of-life reporting in randomized controlled trials shaping the EAU Renal Cell Carcinoma Guidelines. November 21, 2022

An exploratory study of CT radiomics using differential network feature selection for WHO/ISUP grading and progression-free survival prediction of clear cell renal cell carcinoma. November 21, 2022

LINC00472 inhibits cell migration by enhancing intercellular adhesion and regulates H3K27ac level via interacting with P300 in renal clear cell carcinoma. November 18, 2022

Novel Retroperitoneal Neovascularity Scoring System in Renal Cell Carcinoma Tumor Staging. November 18, 2022

A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy--A large, retrospective, single-center study. November 17, 2022

Hot topics in renal cancer pathology: implications for clinical management. November 17, 2022

An enhancer demethylator phenotype converged to immune dysfunction and resistance to immune checkpoint inhibitors in clear-cell renal cell carcinomas. November 16, 2022

Predicting short- and long-term renal function following partial and radical nephrectomy. November 16, 2022

Impact of Partial Nephrectomy and Percutaneous Cryoablation on Short-term Health-related Quality of Life-A Prospective Comparative Cohort Study. November 15, 2022

Characterizing Tumor Thrombus Arising from Non-Clear Cell Renal Cell Carcinoma. November 15, 2022

Adjuvant therapy options in renal cell carcinoma - targeting the metastatic cascade. November 15, 2022

Page 61 of 456